|
"liu sc"的相關文件
顯示項目 31-55 / 99 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2015-09-01 |
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients
|
Liu, SW;Liu, YL;Hwang, LL;Wang, SC;Kuo, HW;Wu, SL;Dai, YWE;Liu, SC;Ho, IK;Chen, ACH;Hsiao, CF;Tsou, HH |
| 亞洲大學 |
2015-01 |
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment
|
Wang, SW;Wang, SW;Liu, SC;Liu, SC;Sun, HL;Sun, HL;Huang, TY;Huang, TY;Chan, CH;Chan, CH;Yang, CY;Yang, CY;Yeh, HI;Yeh, HI;黃元勵;HUANG, YUAN-LI;Chou WY, ;Lin YM, ;Tang, CH;Tang, CH |
| 國立交通大學 |
2014-12-08T15:49:02Z |
Characterization and reduction of phase noise in passively mode-locked Ti : sapphire lasers with intracavity saturable absorbers
|
Shieh, JM; Liu, SC; Pan, CL |
| 國立交通大學 |
2014-12-08T15:16:17Z |
High-peak-power AlGaInAs quantum-well 1.3-mu m laser pumped by a diode-pumped actively Q-switched solid-state laser
|
Su, KW; Huang, SC; Li, A; Liu, SC; Chen, YF; Huang, KF |
| 國家衛生研究院 |
2014-04 |
The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance
|
Wang, SC;Tsou, HH;Chung, RH;Chang, YS;Fang, CP;Chen, CH;Ho, IK;Kuo, HW;Liu, SC;Shih, YH;Wu, HY;Huang, BH;Lin, KM;Chen, AC;Hsiao, CF;Liu, YL |
| 亞洲大學 |
2014 |
Association Study Between Macrophage Migration Inhibitory Factor-173 Polymorphism and Acute Myeloid Leukemia in Taiwan.
|
Ramireddy, L;Ramireddy, L;Lin, CY;Lin, CY;Liu, SC;Liu, SC;Lo, WY;Lo, WY;胡若梅;Hu, Rouh-Mei;Peng, YC;Peng, YC;彭慶添 |
| 國家衛生研究院 |
2013-12-02 |
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
|
Liu, SC;Tsang, NM;Chiang, WC;Chang, KP;Hsueh, C;Liang, Y;Juang, JL;Chow, KPN;Chang, YS |
| 國家衛生研究院 |
2013-09 |
Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort
|
Wang, SC;Ho, IK;Tsou, HH;Liu, SW;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Liu, SC;Wu, HY;Kuo, HW;Chen, AC;Chang, YS;Liu, YL |
| 國家衛生研究院 |
2013-07 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang, YS;Yeh, TK;Chen, AC;Liu, YL |
| 臺北醫學大學 |
2013 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang |
| 國家衛生研究院 |
2012-10 |
Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients
|
Wang, SC;Tsou, HH;Chen, CH;Chen, YT;Ho, IK;Hsiao, CF;Chou, SY;Lin, YF;Fang, KC;Huang, CL;Su, LW;Fang, YC;Liu, ML;Wu, HY;Lin, KM;Liu, SC;Kuo, HW;Chiang, IC;Chen, AC;Tian, JN;Liu, YL |
| 國家衛生研究院 |
2012-06 |
UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients
|
Tian, JN;Ho, IK;Tsou, HH;Fang, CP;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, YT;Liu, SC;Hsu, YT;Kuo, HW;Liu, CT;Yang, YT;Chen, A;Shih, YH;Liu, YL |
| 國家衛生研究院 |
2012-03 |
Risk of asthma associated with energy-dense but nutrient-poor dietary pattern in Taiwanese children
|
Lee, SC;Yang, YH;Chuang, SY;Liu, SC;Yang, HC;Pan, WH |
| 國家衛生研究院 |
2011-10 |
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients
|
Chen, CH;Wang, SC;Tsou, HH;Ho, IK;Tian, JN;Yu, CJ;Hsiao, CF;Chou, SY;Lin, YF;Fang, KC;Huang, CL;Su, LW;Fang, YC;Liu, ML;Lin, KM;Hsu, YT;Liu, SC;Chen, AC;Liu, YL |
| 中國醫藥大學 |
2011-10 |
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients
|
(Chen CH);(Wang SC);(Tsou HH);(Ho IK);(Tian JN);(Yu CJ);(Hsiao CF);(Chou SY);(Lin YF);(Fang KC);黃介良(Chieh-Liang Huang);(Su LW);(Fang YC);(Liu ML);(Lin KM);(Hsu YT);(Liu SC);(Chen AC);(Liu YL)* |
| 國家衛生研究院 |
2011-08 |
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer
|
Wang, SC;Ho, IK;Tsou, HH;Tian, JN;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Chen, CY;Liu, SC;Wu, HY;Chan, HW;Tsai, MH;Lin, PS;Liu, YL |
| 中國醫藥大學 |
2011-08 |
CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer
|
(Wang SC);(Ho IK);(Tsou HH);(Tian JN);(Hsiao CF);(Chen CH);(Tan HK);(Lin L);(Wu CS);(Su LW);黃介良(Chieh-Liang Huang);(Yang YH);(Liu ML);(Lin KM);(Chen CY);(Liu SC);(Wu HY);(Chan HW);(sai MH);(Lin PS);(Liu YL)* |
| 國家衛生研究院 |
2011-05 |
Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine
|
Liu, YL;Lin, KM;Tsou, HH;Tian, JN;Chen, CH;Shen, WW;Lu, SC;Liu, CY;Hsiao, MC;Tang, HS;Liu, SI;Chang, LH;Hsiao, CF;Kuo, HW;Hsu, YT;Liu, SC;Tu, SL |
| 國家衛生研究院 |
2011-05 |
The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction
|
Tian, JN;Wang, SC;Chen, CH;Tsou, HH;Ho, IK;Chan, HW;Fang, CP;Hsiao, CF;Tan, HKL;Lin, LN;Wu, CS;Su, LW;Huang, CL;Yang, YH;Wu, JY;Lin, KM;Chen, CY;Liu, SC;Liu, YL |
| 國家衛生研究院 |
2011-05 |
Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine
|
Chan, HW;Tsou, HH;Tian, JN;Lin, KM;Hsiao, MC;Shen, WW;Lu, ML;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Liu, SC;Chen, CY;Liu, YL |
| 國家衛生研究院 |
2011-05 |
Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients
|
Tian, JN;Wang, SC;Ho, IK;Tsou, HH;Lin, KM;Hsiao, CF;Chen, CH;Tan, HKL;Lin, LN;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, CY;Liu, SC;Wu, HY;Kuo, HW;Liu, YL |
| 國家衛生研究院 |
2011-04 |
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment
|
Lin, KM;Chiu, YF;Tsai, IJ;Chen, CH;Shen, WW;Liu, SC;Lu, SC;Liu, CY;Hsiao, MC;Tang, HS;Liu, SI;Chang, LH;Wu, CS;Tsou, HH;Tsai, MH;Chen, CY;Wang, SM;Kuo, HW;Hsu, YT;Liu, YL |
| 國家衛生研究院 |
2010-11 |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
Lin, KM;Tsou, HH;Tsai IJ;Hsiao, MC;Hsiao, CF;Liu CY;Shen, WW;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Kuo, HW;Liu, SC;Chan, HW;Hsu, YT;Tian, JN;Liu, YL |
| 國家衛生研究院 |
2010-07 |
Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients
|
Wang, SC;Ho, IK;Wu, SL;Liu, SC;Kuo, HW;Lin, KM;Liu, YL |
| 國家衛生研究院 |
2010-04 |
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response
|
Tsai, MH;Lin, KM;Hsiao, MC;Shen, WW;Lu, ML;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Liu, SC;Chen, CY;Liu, YL |
顯示項目 31-55 / 99 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
